573 related articles for article (PubMed ID: 23146511)
1. How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?
Antoniou E; Mantas D; Paraskeva P; Dimitroulis D; Smyrnis A; Nikitakis N; Labadariou A; Tsavaris N; Vernicos P; Kostakis A
Transplant Proc; 2012 Nov; 44(9):2745-7. PubMed ID: 23146511
[TBL] [Abstract][Full Text] [Related]
2. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
4. Liver resection associated with mini porto-caval shunt as salvage treatment in patients with progression of hepatocellular carcinoma before liver transplantation: a case report.
Polacco M; Vitale A; Valmasoni M; D'Amico F; Gringeri E; Brolese A; Zanus G; Neri D; Carraro A; Pauletto A; Romanelli E; Lo Bello S; Cillo U
Transplant Proc; 2010 May; 42(4):1378-80. PubMed ID: 20534307
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
7. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
[TBL] [Abstract][Full Text] [Related]
8. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
9. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
[TBL] [Abstract][Full Text] [Related]
10. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
[TBL] [Abstract][Full Text] [Related]
12. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
13. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation outcomes in patients with cirrhosis and hepatocellular carcinoma: experience of a single center in a viral hepatitis endemic area.
Imvrios G; Papanikolaou V; Vrochides D; Ouzounidis N; Papagiannis A; Fouzas I; Giakoustidis D; Antoniades N; Iosifidou S; Patsiaoura K; Zafiriadou E; Takoudas D
Transplant Proc; 2007 Jun; 39(5):1508-10. PubMed ID: 17580174
[TBL] [Abstract][Full Text] [Related]
17. Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review.
Schreibman IR; Bejarano P; Martinez EJ; Regev A
Transplant Proc; 2006 Nov; 38(9):3140-3. PubMed ID: 17112921
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
19. [Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
Kobayashi K; Ueki K; Ishizuka D; Wakakuwa R
Gan To Kagaku Ryoho; 2005 Mar; 32(3):389-91. PubMed ID: 15791824
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation.
Bernal E; Montero JL; Delgado M; Fraga E; Costán G; Barrera P; López-Vallejos P; Solórzano G; Rufián S; Briceño J; Padillo J; López-Cillero P; Marchal T; Muntané J; de la Mata M
Transplant Proc; 2006 Oct; 38(8):2495-8. PubMed ID: 17097979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
